Anthracycline Cardiotoxicity Is Associated With Elevated β1‐Adrenergic Receptor Density

Anthracycline Cardiotoxicity Is Associated With Elevated β1‐Adrenergic Receptor Density

Bibliographic Details
Main Authors:	Manveen K. Gupta, Yu Sun, Kate T. Stenson, Sathyamangla V. Naga Prasad
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	adriamycin cardiotoxicity beta‐adrenergic receptor cardiac dilation ubiquitination
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.023457

Similar Items

Different preventive effects of four cardioprotective agents on mice with adriamycin-induced cardiotoxicity
by: CHEN Yifan, SHEN Yihui, CHENG Leilei, LIN Jinyi, ZHANG Hui, WANG Xuejun, XU Yuchen, ZHANG Jian, GE Junbo
Published: (2022-10-01)

Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity
by: Zhenxing Liang, et al.
Published: (2022-09-01)

Potential chemoprotective effects of active ingredients in Salvia miltiorrhiza on doxorubicin-induced cardiotoxicity: a systematic review of in vitro and in vivo studies
by: Qingqing Wang, et al.
Published: (2023-10-01)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
by: Leila Mabudian, et al.
Published: (2022-09-01)

In vivo and molecular docking studies of the pathological mechanism underlying adriamycin cardiotoxicity
by: Fangfang Duan, et al.
Published: (2023-05-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
by: Alexandros Briasoulis, et al.
Published: (2022-02-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
by: Marialucia Telesca, et al.
Published: (2023-12-01)

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
by: Dongsheng He, et al.
Published: (2022-08-01)

Regulation of bone formation and resorption by Beta Adrenergic system
by: Fateme Mohammadali, et al.
Published: (2016-04-01)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
by: Ryan N. Montalvo, et al.
Published: (2020-10-01)

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity
by: René R. Sevag Packard, et al.
Published: (2023-01-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
by: Yun Qiu, et al.
Published: (2023-12-01)

Adrenergic Receptors and Metabolism: Role in development of cardiovascular disease
by: Michele eCiccarelli, et al.
Published: (2013-10-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Genetics of Anthracycline-Associated Cardiotoxicity
by: Talal Khalid Al-Otaibi, et al.
Published: (2022-04-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues
by: Lauriane Y. M. Michel, et al.
Published: (2020-12-01)

Beta adrenergic blokade in myocardial infarction
by: Yusuf, S
Published: (1980)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020-02-01)

A journey in anthracycline-induced cardiotoxicity with emphasizing on doxorubicin: a review article
by: Atlasi Safaei, et al.
Published: (2021-11-01)

Construction of a mouse model of adriamycin-induced cardiomyopathy
by: ZHANG Qingling, ZHANG Yunpeng, ZHOU Zandong, ZHANG Yue, LIU Tong
Published: (2022-10-01)

Assessing cardiotoxicity in randomised trials of anthracycline chemotherapy
by: Kerr, A
Published: (2016)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
by: Aleksandra M. Sobiborowicz-Sadowska, et al.
Published: (2023-01-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
by: Maryam Moossavi, et al.
Published: (2023-03-01)

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
by: Ahmed Ayuna, et al.
Published: (2020-09-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Sex-Related Effects of Prenatal Stress on Region-Specific Expression of Monoamine Oxidase A and β Adrenergic Receptors in Rat Hearts
by: Tanja Jevjdovic, et al.
Published: (2018-12-01)

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
by: Guoxia Zhang, et al.
Published: (2022-06-01)

Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters
by: Belén Díaz‐Antón, et al.
Published: (2022-04-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy
by: Sanela Dozic, et al.
Published: (2023-05-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Review of Recent Laboratory and Experimental Data on Cardiotoxicity of Statins
by: Aleksey M. Chaulin
Published: (2022-11-01)